Early diagnosis, better prognosis.
We are Reccan, a young medtech company dedicated to improving the prognosis for patients diagnosed with pancreatic cancer.
Our vision is to set a standard for early detection of pancreatic cancer and therefore save lives.
We are working to change the trajectory of pancreatic cancer mortality by finding the cancer at an earlier stage than is possible today. Early detection makes interventions and treatments more effective.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Scheeletorget 1, 223 63 Lund, Medicon Village,the Spark,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Lund
Reccan Ab Questions
Reccan Ab's website is https://www.reccandiagnostics.com/
Reccan Ab's LinkedIn profile is https://se.linkedin.com/company/reccan-ab
Reccan Ab has
3 employees.
View email and phone details for 3
employees at Reccan Ab.
Reccan Ab's industry is
Biotechnology Research
Reccan Ab's top competitors are
Cytely Ab,
Strike Pharma Ab,
Colzyx,
Life Science Invest,
Stairway Medical,
2n Pharma,
Lead Biologics,
Medeon Science Park,
Neola Medical,
Trackpaw Scientific Ab.
Reccan Ab's categories are Biotechnology Research
Reccan Ab's founding year is 2014
